Somatostatin Analogs Market 2028 Indication, Type Diseases, End User | The Insight Partners

report image

Somatostatin Analogs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Indication (Acromegaly, NETs, Others); Type (Octreotide, Lanreotide, Pasireotide) Diseases, Immunological Disorders, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, Others); End User (Medical Device Companies, Biopharmaceutical Companies, Others)

Report Code: TIPRE00010493 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Somatostatin analogs are used for the treatment of tumors secreting vasoactive intestinal peptide, carcinoid tumors, glucagonomas, and multiple pituitary adenomas. It is also used to treat acromegaly (a condition where there is over secretion of growth hormone in an adult). Somatostatin is a hormone that is produced by many tissues in the body, principally in the nervous and digestive systems.


The somatostatin analogs market is anticipated to grow due to rising incidences of NETs. However, lack of awareness leading to a high number of undiagnosed people is hampering the market growth. Moreover, increasing research and development activity in the somatostatin analogs market has resulted in the increased usage of already existing drug molecules that are expected to drive the growth of the market in the forecast period.


The "Somatostatin Analogs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of somatostatin analogs market with detailed market segmentation by type, and indication. The somatostatin analogs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in somatostatin analogs market and offers key trends and opportunities in the market.


The somatostatin analogs market is segmented on the basis of type, and indication. Based on type the market is segmented as octreotide, lanreotide, and pasireotide. On the basis of indication the market is categorized as acromegaly, NETs, and others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the somatostatin analogs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The somatostatin analogs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting somatostatin analogs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the somatostatin analogs market in these regions.

Get more information on this report :


The report covers key developments in the somatostatin analogs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from somatostatin analogs market are anticipated to have lucrative growth opportunities in the future with the rising demand for somatostatin analogs in the global market. Below mentioned is the list of few companies engaged in the somatostatin analogs market.

The report also includes the profiles of key players in somatostatin analogs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Chiasma Inc.
  •   Dauntless Pharmaceuticals
  •   Ipsen Pharma
  •   Midatech Pharma PLC
  •   Novartis AG
  •   Peptron, Inc.
  •   Pfizer Inc.
  •   Sun Pharmaceutical Industries Ltd
  •   Teva Pharmaceuticals Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Chiasma Inc.
3. Dauntless Pharmaceuticals
4. Ipsen Pharma
5. Midatech Pharma PLC
6. Novartis AG
7. Peptron, Inc.
8. Pfizer Inc.
9. Sun Pharmaceutical Industries Ltd
10. Teva Pharmaceuticals Inc
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount